IRBESARTAN — all Canadian products
173 DINs
66 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is IRBESARTAN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02548216 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02548232 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02548224 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02241818 | AVALIDE | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02241819 | AVALIDE | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02237924 | AVAPRO | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02237925 | AVAPRO | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02396033 | IRBESARTAN | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 300 MG | Approved | |
| 02396017 | IRBESARTAN | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 75 MG | Approved | |
| 02396025 | IRBESARTAN | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 150 MG | Approved | |
| 02372347 | IRBESARTAN | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02385295 | IRBESARTAN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02385309 | IRBESARTAN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02385287 | IRBESARTAN | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02372371 | IRBESARTAN | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02372398 | IRBESARTAN | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02404028 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved | |
| 02404001 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved | |
| 02404036 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | JUBILANT GENERICS LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Approved | |
| 02385333 | IRBESARTAN HCT | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 02385325 | IRBESARTAN HCT | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02385317 | IRBESARTAN HCT | SIVEM PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02545233 | JAMP IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02545225 | JAMP IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02545241 | JAMP IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02524813 | M-IRBESARTAN | MANTRA PHARMA INC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02524848 | M-IRBESARTAN | MANTRA PHARMA INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02524821 | M-IRBESARTAN | MANTRA PHARMA INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02423006 | MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02422980 | MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02422999 | MINT-IRBESARTAN | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02560070 | NB-IRBESARTAN | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02560097 | NB-IRBESARTAN | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02560089 | NB-IRBESARTAN | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02570211 | NB-IRBESARTAN HCT | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved | |
| 02570246 | NB-IRBESARTAN HCT | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Approved | |
| 02570238 | NB-IRBESARTAN HCT | NB PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved | |
| 02427222 | PENDO-IRBESARTAN | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 300 MG | Approved | |
| 02427214 | PENDO-IRBESARTAN-HCTZ | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Approved | |
| 02317060 | PMS-IRBESARTAN | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02317087 | PMS-IRBESARTAN | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02317079 | PMS-IRBESARTAN | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02328534 | PMS-IRBESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 02328526 | PMS-IRBESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02328518 | PMS-IRBESARTAN-HCTZ | PHARMASCIENCE INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02365197 | PRO-IRBESARTAN | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02365200 | PRO-IRBESARTAN | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02365219 | PRO-IRBESARTAN | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02365189 | PRO-IRBESARTAN-HCTZ | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 02365170 | PRO-IRBESARTAN-HCTZ | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02365162 | PRO-IRBESARTAN-HCTZ | PRO DOC LIMITEE | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02524759 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02524732 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02524740 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02328488 | SANDOZ IRBESARTAN | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02328461 | SANDOZ IRBESARTAN | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02328496 | SANDOZ IRBESARTAN | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02337444 | SANDOZ IRBESARTAN HCT | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 02337436 | SANDOZ IRBESARTAN HCT | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02337428 | SANDOZ IRBESARTAN HCT | SANDOZ CANADA INCORPORATED | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02406810 | SPC-IRBESARTAN | SUN PHARMA CANADA INC | Tablet | Oral | IRBESARTAN 75 MG | Marketed | |
| 02406829 | SPC-IRBESARTAN | SUN PHARMA CANADA INC | Tablet | Oral | IRBESARTAN 150 MG | Marketed | |
| 02406837 | SPC-IRBESARTAN | SUN PHARMA CANADA INC | Tablet | Oral | IRBESARTAN 300 MG | Marketed | |
| 02330512 | TEVA-IRBESARTAN HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02330520 | TEVA-IRBESARTAN HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Marketed | |
| 02330539 | TEVA-IRBESARTAN HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed | |
| 02328100 | ACT IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02328089 | ACT IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02328070 | ACT IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02357402 | ACT IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02357399 | ACT IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02357410 | ACT IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02474417 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02474395 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02474409 | AG-IRBESARTAN | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02476428 | AG-IRBESARTAN HCTZ | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02476436 | AG-IRBESARTAN HCTZ | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02476444 | AG-IRBESARTAN HCTZ | ANGITA PHARMA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02386968 | APO-IRBESARTAN | APOTEX INC | Tablet | Oral | IRBESARTAN 75 MG | Dormant | |
| 02386976 | APO-IRBESARTAN | APOTEX INC | Tablet | Oral | IRBESARTAN 150 MG | Dormant | |
| 02386984 | APO-IRBESARTAN | APOTEX INC | Tablet | Oral | IRBESARTAN 300 MG | Dormant | |
| 02387654 | APO-IRBESARTAN/HCTZ | APOTEX INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02387662 | APO-IRBESARTAN/HCTZ | APOTEX INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Dormant | |
| 02387646 | APO-IRBESARTAN/HCTZ | APOTEX INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02406128 | AURO-IRBESARTAN | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 300 MG | Dormant | |
| 02406098 | AURO-IRBESARTAN | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 75 MG | Dormant | |
| 02406101 | AURO-IRBESARTAN | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 150 MG | Dormant | |
| 02447886 | AURO-IRBESARTAN HCT | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02447894 | AURO-IRBESARTAN HCT | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Dormant | |
| 02447878 | AURO-IRBESARTAN HCT | AURO PHARMA INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02373319 | AVA-IRBESARTAN | AVANSTRA INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02373327 | AVA-IRBESARTAN | AVANSTRA INC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02373335 | AVA-IRBESARTAN | AVANSTRA INC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02373378 | AVA-IRBESARTAN/HCTZ | AVANSTRA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02373343 | AVA-IRBESARTAN/HCTZ | AVANSTRA INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02373351 | AVA-IRBESARTAN/HCTZ | AVANSTRA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02280213 | AVALIDE | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02237923 | AVAPRO | SANOFI-AVENTIS CANADA INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02446154 | BIO-IRBESARTAN | BIOMED PHARMA | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02446162 | BIO-IRBESARTAN | BIOMED PHARMA | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02446146 | BIO-IRBESARTAN | BIOMED PHARMA | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02372193 | DOM-IRBESARTAN | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02372185 | DOM-IRBESARTAN | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02372207 | DOM-IRBESARTAN | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02372231 | DOM-IRBESARTAN-HCTZ | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02372223 | DOM-IRBESARTAN-HCTZ | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02372266 | DOM-IRBESARTAN-HCTZ | DOMINION PHARMACAL | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market | |
| 02435438 | IPG-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02435454 | IPG-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02435446 | IPG-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02433842 | IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02414635 | IRBESARTAN | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02414643 | IRBESARTAN | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02414651 | IRBESARTAN | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02433826 | IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02433834 | IRBESARTAN | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02434261 | IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02434296 | IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market | |
| 02434288 | IRBESARTAN/HCT | ACTAVIS PHARMA COMPANY | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02372886 | IRBESARTAN/HCTZ | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02372908 | IRBESARTAN/HCTZ | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Dormant | |
| 02372894 | IRBESARTAN/HCTZ | SANIS HEALTH INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Dormant | |
| 02418193 | JAMP-IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02418207 | JAMP-IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02418215 | JAMP-IRBESARTAN | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02418223 | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02418258 | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02418231 | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | JAMP PHARMA CORPORATION | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02436124 | MAR-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02436108 | MAR-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02436116 | MAR-IRBESARTAN | MARCAN PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02392992 | MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02393018 | MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02393026 | MINT-IRBESARTAN/HCTZ | MINT PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02347326 | MYLAN-IRBESARTAN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02347296 | MYLAN-IRBESARTAN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02347318 | MYLAN-IRBESARTAN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02376873 | MYLAN-IRBESARTAN HCTZ | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02376903 | MYLAN-IRBESARTAN HCTZ | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market | |
| 02376881 | MYLAN-IRBESARTAN HCTZ | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02368994 | NTP-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02368978 | NTP-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02368986 | NTP-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02368951 | NTP-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market | |
| 02368943 | NTP-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02368935 | NTP-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02446499 | PRIVA-IRBESARTAN | PHARMAPAR INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02446502 | PRIVA-IRBESARTAN | PHARMAPAR INC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02446510 | PRIVA-IRBESARTAN | PHARMAPAR INC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02393530 | Q-IRBESARTAN | QD PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Pre Market | |
| 02393522 | Q-IRBESARTAN | QD PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Pre Market | |
| 02393514 | Q-IRBESARTAN | QD PHARMACEUTICALS ULC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Pre Market | |
| 02363224 | RAN-IRBESARTAN HCTZ | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02363208 | RAN-IRBESARTAN HCTZ | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02363216 | RAN-IRBESARTAN HCTZ | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02425327 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02425319 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02425335 | RIVA-IRBESARTAN | LABORATOIRE RIVA INC. | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02316390 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02316005 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02315998 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02315971 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02316412 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02316404 | TEVA-IRBESARTAN | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02316021 | TEVA-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02316048 | TEVA-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market | |
| 02316013 | TEVA-IRBESARTAN/HCTZ | TEVA CANADA LIMITED | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Post Market | |
| 02427095 | VAN-IRBESARTAN | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG | Cancelled Post Market | |
| 02427087 | VAN-IRBESARTAN | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 75 MG | Cancelled Post Market | |
| 02427109 | VAN-IRBESARTAN | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG | Cancelled Post Market | |
| 02427060 | VAN-IRBESARTAN-HCTZ | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02427052 | VAN-IRBESARTAN-HCTZ | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 150 MG; HYDROCHLOROTHIAZIDE 12.5 MG | Cancelled Pre Market | |
| 02427079 | VAN-IRBESARTAN-HCTZ | VANC PHARMACEUTICALS INC | Tablet | Oral | IRBESARTAN 300 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Pre Market |
Browse other molecules: